Bruker CorporationBRKRNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 56% recommend buying.

Consensus Rating

Buy

27 analysts·High coverage

56%

Rating Distribution

Strong Buy

00%

Buy

1556%

Hold

1141%

Sell

14%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 20% higher.

Bear Case

$40.00

-9%

Consensus

$52.33

+20%

Bull Case

$60.00

+37%

Price Range27 analysts

Low

Consensus

High

$40.00

$60.00

Current Target

Current Price

$43.75

Upside to Target

$8.58

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$2.14(8 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+4.97%

EPS+13.50%

FY2028

Rev+6.29%

EPS+11.55%

FY2029

Rev+3.42%

EPS+13.43%

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+11.9%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 26, 2026Guggenheim

Bruker price target raised to $58 from $53 at Guggenheim

Target:$58.00

+18.3%from $49.02

Jan 5, 2026Guggenheim

Bruker price target raised to $53 from $45 at Guggenheim

Target:$53.00

+6.3%from $49.87

Dec 15, 2025Wells Fargo

Bruker price target raised to $55 from $48 at Wells Fargo

Target:$55.00

+21.9%from $45.13

Dec 15, 2025Barclays

Bruker price target raised to $55 from $45 at Barclays

Target:$55.00

+21.9%from $45.13

Dec 10, 2025Wolfe Research

Wolfe upgrades Bruker to Outperform on 2026 growth

Target:$60.00

+25.9%from $47.65

Dec 9, 2025Goldman Sachs

Bruker initiated with a Sell at Goldman Sachs

Target:$40.00

-13.0%from $46.00

Nov 20, 2025Redburn Partners

Bruker initiated with a Buy at Rothschild & Co Redburn

Target:$60.00

+38.3%from $43.39

Nov 4, 2025UBS

Bruker price target raised to $43 from $40 at UBS

Target:$43.00

+11.1%from $38.71

Nov 4, 2025Barclays

Bruker price target raised to $45 from $40 at Barclays

Target:$45.00

+16.2%from $38.71

Oct 2, 2025Barclays

Bruker price target lowered to $40 from $43 at Barclays

Target:$40.00

+15.2%from $34.72

Aug 5, 2025Stifel Nicolaus

Bruker price target lowered to $40 from $48 at Stifel

Target:$40.00

+24.7%from $32.07

Aug 4, 2025Barclays

Bruker price target lowered to $43 from $46 at Barclays

Target:$43.00

+23.8%from $34.72

Aug 4, 2025Jefferies

Bruker price target lowered to $60 from $70 at Jefferies

Target:$60.00

+72.8%from $34.72

Dec 19, 2024Guggenheim

Bruker initiated with a Buy at Guggenheim

Target:$72.00

+29.2%from $55.74

Sep 23, 2024Citigroup

Citi Reiterates Buy Rating on Bruker (BRKR)

Target:$80.00

+18.4%from $67.54

Aug 27, 2024Wells Fargo

Bruker initiated with an Overweight at Wells Fargo

Target:$78.00

+22.0%from $63.95

May 20, 2024Stifel Nicolaus

Bruker (BRKR) PT Lowered to $77 at Stifel

Target:$77.00

+0.7%from $76.47

May 5, 2021J.P. Morgan

Bruker (BRKR) PT Raised to $60 at JPMorgan, Following Earnings

Target:$60.00

-12.9%from $68.86

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance